CIK: 0001535610
申告総資産額
$4507.3万
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AZN | AstraZeneca PLC | 株式-ヘルスケア | 11.27% | — | -2.01% | |
| 2 | BIIB | Biogen INC | 株式-ヘルスケア | 11.02% | — | — | |
| 3 | ✓ | Esperion Therapeutics INC Ne | 株式-その他 | 9.63% | — | +262.46% | |
| 4 | ✓ | Ishares Tr | 株式-その他 | 8.35% | -19.97% | EXIT | |
| 5 | AZN | AstraZeneca PLC | 株式-ヘルスケア | 6.45% | — | +11.57% | |
| 6 | SRPT | Sarepta Therapeutics, Inc. | 株式-ヘルスケア | 3.80% | — | -74.14% | |
| 7 | ✓ | Zogenix INC | 株式-その他 | 3.58% | — | +31.36% | |
| 8 | ✓ | Odonate Therapeu | 株式-その他 | 3.42% | — | -11.05% | |
| 9 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型株・グロース | 2.58% | +3.61% | — | |
| 10 | ✓ | Incyte CORP | 株式-その他 | 2.37% | — | +25.00% | |
| 11 | ✓ | Incyte CORP | 株式-その他 | 2.09% | — | +114.29% | |
| 12 | ✓ | Unum Therapeutics INC | 株式-その他 | 2.06% | — | — | |
| 13 | ✓ | 株式-その他 | 1.70% | — | +30.16% | ||
| 14 | INCY | Incyte CORP | 株式-ヘルスケア | 1.50% | — | — | |
| 15 | ✓ | Spark Therapeutics INC | 株式-その他 | 1.49% | — | — | |
| 16 | ✓ | Sarepta Therapeutics INC | 株式-その他 | 1.45% | — | -39.67% | |
| 17 | ✓ | Sangamo Therapeutics INC | 株式-その他 | 1.42% | — | +24.03% | |
| 18 | NKTREUR | Nektar Therapeutics | 株式-その他 | 1.38% | — | +194.16% | |
| 19 | ✓ | Spark Therapeutics INC | 株式-その他 | 1.14% | — | — | |
| 20 | ✓ | Alkermes PLC | 株式-その他 | 0.86% | — | -57.72% | |
| 21 | ✓ | Esperion Therapeutics INC Ne | 株式-その他 | 0.86% | — | +367.83% | |
| 22 | ✓ | Global Blood Therapeutics INC | 株式-その他 | 0.81% | — | — | |
| 23 | RKDAEUR | Arcadia Biosciences INC | 株式-その他 | 0.79% | — | — | |
| 24 | ✓ | Alnylam Pharmaceuticals INC | 株式-その他 | 0.66% | — | -84.40% | |
| 25 | ✓ | 株式-その他 | 0.65% | — | — | ||
| 26 | ✓ | Zogenix INC | 株式-その他 | 0.61% | — | -38.33% | |
| 27 | SGMOQ | Sangamo Therapeutics INC | 株式-その他 | 0.59% | — | — | |
| 28 | ✓ | Spdr S&p 500 ETF Tr | ETF-大型株・グロース | 0.57% | +30.26% | — | |
| 29 | ✓ | Amarin Corp PLC | 株式-その他 | 0.55% | — | +244.04% | |
| 30 | ✓ | Aveo Pharmaceuticals INC | 株式-その他 | 0.55% | — | +6925.41% | |
| 31 | ✓ | Acceleron Pharma INC | 株式-その他 | 0.45% | — | — | |
| 32 | ✓ | Citius Pharmaceuticals INC | 株式-その他 | 0.44% | — | +205.14% | |
| 33 | ✓ | Amyris INC | 株式-その他 | 0.42% | — | +1028.40% | |
| 34 | ✓ | Oncobiologics INC | 株式-その他 | 0.41% | — | +1.39% | |
| 35 | ✓ | Achaogen INC | 株式-その他 | 0.40% | — | — | |
| 36 | ✓ | 株式-その他 | 0.39% | — | — | ||
| 37 | SLNOEUR | Soleno Therapeutics INC | 株式-その他 | 0.37% | — | +0.30% | |
| 38 | NOVN1EUR | Novan INC | 株式-その他 | 0.35% | — | — | |
| 39 | ✓ | Cellect Biotechnology LTD | 株式-その他 | 0.34% | — | — | |
| 40 | ✓ | Amicus Therapeutics INC | 株式-その他 | 0.33% | — | -90.31% | |
| 41 | ✓ | Amicus Therapeutics INC | 株式-その他 | 0.33% | — | -50.00% | |
| 42 | ✓ | Pavmed INC | 株式-その他 | 0.33% | — | — | |
| 43 | BMY | Bristol-myers Squibb Co | 株式-ヘルスケア | 0.32% | — | -97.50% | |
| 44 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 0.30% | — | -40.26% | |
| 45 | ESPR | Esperion Therapeutics INC | 株式-その他 | 0.30% | — | -86.76% | |
| 46 | ✓ | Prothena CORP PLC | 株式-その他 | 0.29% | — | — | |
| 47 | ✓ | Eleven Biotherapeutics INC | 株式-その他 | 0.28% | — | — | |
| 48 | ✓ | Insmed INC | 株式-その他 | 0.27% | — | — | |
| 49 | ✓ | Ovascience INC | 株式-その他 | 0.26% | — | +143.59% | |
| 50 | ZSANEUR | Zosano Pharma CORP | 株式-その他 | 0.26% | — | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | BIIB | Biogen Inc. | +5.7% | +800.43% | 増加 |
| 2 | ✓ | Esperion Therapeutics INC Ne | +4.2% | +262.46% | 増加 |
| 3 | ✓ | Zogenix INC | +0.8% | +31.36% | 増加 |
| 4 | ✓ | Incyte CORP | +0.7% | +114.29% | 増加 |
| 5 | NKTREUR | Nektar Therapeutics | +0.6% | +194.16% | 増加 |
| 6 | ✓ | +0.6% | +30.16% | 増加 | |
| 7 | ✓ | Alexion Pharmaceuticals INC | +0.5% | +140.08% | 増加 |
| 8 | ✓ | Odonate Therapeu | 0% | -11.05% | 減少 |
| 9 | ✓ | Alkermes PLC | -0.3% | -57.72% | 減少 |
| 10 | ESPR | Esperion Therapeutics INC | -0.7% | -86.76% | 減少 |
| 11 | ✓ | Sangamo Therapeutics INC | -0.9% | -96.21% | 減少 |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | -1.2% | +43.09% | 増加 |
| 13 | ✓ | Amicus Therapeutics INC | -1.2% | -90.31% | 減少 |
| 14 | MRK | Merck & Co., Inc. | -1.3% | -95.48% | 減少 |
| 15 | ✓ | Ishares Tr | -1.3% | -40.55% | 減少 |
| 16 | ✓ | Alnylam Pharmaceuticals INC | -1.5% | -84.40% | 減少 |
| 17 | SRPT | Sarepta Therapeutics, Inc. | -2.5% | -74.14% | 減少 |
| 18 | BMY | Bristol-myers Squibb Co | -5% | -97.50% | 減少 |
| 19 | MRK | Merck & Co., Inc. | -7.7% | -86.34% | 減少 |
| 20 | BMY | Bristol-Myers Squibb Company | -19.2% | -99.19% | 減少 |
| 21 | ✓ | Spdr S&p 500 ETF Tr | — | NEW | 新規購入 |
| 22 | ✓ | Bluebird Bio INC | — | EXIT | 全売却 |
| 23 | SPY | State Street SPDR S&P 500 ETF Trust | — | EXIT | 全売却 |
| 24 | BIIB | Biogen INC | — | NEW | 新規購入 |
| 25 | ✓ | Ishares Tr | — | NEW | 新規購入 |
| 26 | BMY | Bristol-Myers Squibb Company | — | EXIT | 全売却 |
| 27 | ✓ | Juno Therapeutics INC | — | EXIT | 全売却 |
| 28 | CI | The Cigna Group | — | EXIT | 全売却 |
| 29 | ✓ | Alnylam Pharmaceuticals INC | — | EXIT | 全売却 |
| 30 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | 新規購入 |
| 31 | ✓ | Halozyme Therapeutics INC | — | EXIT | 全売却 |
| 32 | ✓ | Spdr Series Trust | — | NEW | 新規購入 |
| 33 | ✓ | Unum Therapeutics INC | — | NEW | 新規購入 |
| 34 | ✓ | Bluebird Bio INC | — | EXIT | 全売却 |
| 35 | ABBV | AbbVie Inc. | — | EXIT | 全売却 |
| 36 | VRTX | Vertex Pharmaceuticals Incorporated | — | EXIT | 全売却 |
| 37 | ✓ | Ionis Pharmaceuticals INC | — | EXIT | 全売却 |
| 38 | INCY | Incyte CORP | — | NEW | 新規購入 |
| 39 | ✓ | Spark Therapeutics INC | — | NEW | 新規購入 |
| 40 | ✓ | Ionis Pharmaceuticals INC | — | EXIT | 全売却 |
| 41 | ✓ | Sage Therapeutics INC | — | EXIT | 全売却 |
| 42 | ONCEEUR | Spark Therapeutics INC | — | EXIT | 全売却 |
| 43 | ✓ | Spdr S&p Biotech | — | EXIT | 全売却 |
| 44 | ✓ | Spark Therapeutics INC | — | NEW | 新規購入 |
| 45 | ✓ | Radius Health INC | — | EXIT | 全売却 |
| 46 | ✓ | Gw Pharmaceuticals PLC | — | EXIT | 全売却 |
| 47 | ✓ | Sage Therapeutics INC | — | EXIT | 全売却 |
| 48 | ✓ | Global Blood Therapeutics INC | — | NEW | 新規購入 |
| 49 | RKDAEUR | Arcadia Biosciences INC | — | NEW | 新規購入 |
| 50 | GILD | Gilead Sciences, Inc. | — | EXIT | 全売却 |